Drug development for rare neurological diseases
Chord Theraputics News Highlights
6 February 2014: Chord Therapeutics S.a.r.l. incorporated, Geneva Switzerland
19 March 2015: Orphan Drug Designation awarded by US Food and Drug Administration
3 January 2019: AOP Orphan Pharmaceuticals AG and Chord Therapeutics enter agreement.
25 April 2019: USPTO issues Notice of Allowance for key patent.
31 May 2019: Japan Patent Office issues Notice of Allowance for key patent